about
The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysisSorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence.CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study.Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.Nomogram to Predict Survival of Patients with Recurrence of Hepatocellular Carcinoma After Surgery.Response to Ablation and resection for hepatocellular carcinoma within the Milan criteria and high alpha-fetoprotein levels.The efficacy and safety of long- versus short-interval transarterial chemoembolization in unresectable hepatocellular carcinomaImpact of follow-up interval on patients with hepatocellular carcinoma after curative ablationResection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence.Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical TrialLong- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort studyResection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysisMicrowave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysisMicrowave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysisLipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation
P50
Q35441132-4F7098AD-F90F-4A3D-AD6F-E7F3651F5ED7Q37701106-601FB540-892D-4909-A810-52DF2CAFAA98Q40389253-07BE65C9-00B5-4543-AE3E-78BEA667518AQ41750292-F0766F63-C655-47AC-BA4C-4345FDA7B197Q47191908-1E07CEFD-CD4C-4D0B-AD94-F4EFCEA122F6Q53756810-A16543DD-33B3-4CA3-B69A-B13E5D5E8AFBQ58556314-2A59C36B-E28C-4A1F-99A5-3D363E9D8C7CQ59799844-733D58C2-C529-4C6B-B162-2240C919C2A6Q64940826-3AE328A3-1C3D-49AE-B81D-866DC43F4ADBQ86485800-B01EAF69-9D9D-4E56-A162-4AFE13F618B7Q88761252-469A13B1-B947-46AE-A6FC-F4DB19B30680Q89215444-D6B3BC59-4255-4C5F-8CA1-54475B56137AQ90532946-AEE9D76B-92D4-43E0-83BA-232E7547E7D6Q90659238-B4F3CEE7-63D3-4297-9F20-6D71440DA04EQ93143861-8D558D8B-43D1-4F9F-99E5-6AC47F33546A
P50
description
researcher ORCID ID = 0000-0001-5801-9044
@en
name
Wei He
@ast
Wei He
@en
Wei He
@es
Wei He
@nl
type
label
Wei He
@ast
Wei He
@en
Wei He
@es
Wei He
@nl
prefLabel
Wei He
@ast
Wei He
@en
Wei He
@es
Wei He
@nl
P1153
56594081200
P31
P496
0000-0001-5801-9044